128 related articles for article (PubMed ID: 1387390)
21. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers: cytotoxic factor production.
Petit C; Monsigny M; Roche AC
J Biol Response Mod; 1990 Feb; 9(1):33-43. PubMed ID: 2319259
[TBL] [Abstract][Full Text] [Related]
22. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
23. Lipopolysaccharide and liposome-encapsulated MTP-PE-induced cytotoxicity and release of eicosanoids, tumor necrosis factor- alpha and nitric oxide in liver macrophages.
Dieter P; Ambs P; Fitzke E; Schwende H
Adv Exp Med Biol; 1997; 407():485-90. PubMed ID: 9321995
[No Abstract] [Full Text] [Related]
24. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
25. Activation of macrophage cytostatic and cytotoxic activity in vitro by liposomes containing a new lipophilic muramyl peptide derivative, MDP-L-alanyl-cholesterol (MTP-CHOL).
Phillips NC; Moras ML; Chedid L; Petit JF; Tenu JP; Lederer E; Bernard JM; Lefrancier P
J Biol Response Mod; 1985 Oct; 4(5):464-74. PubMed ID: 3935756
[TBL] [Abstract][Full Text] [Related]
26. Liposomal phosphatidylserine inhibits tumor cytotoxicity of liver macrophages induced by muramyl dipeptide and lipopolysaccharide.
Daemen T; Regts J; Scherphof GL
Biochim Biophys Acta; 1996 Dec; 1285(2):219-28. PubMed ID: 8972706
[TBL] [Abstract][Full Text] [Related]
27. Synergistic generation of tumoricidal macrophages by muroctasin and interferon-gamma.
Nagao S; Sato K; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):999-1002. PubMed ID: 3142490
[TBL] [Abstract][Full Text] [Related]
28. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
Fogler WE; Talmadge JE; Fidler IJ
J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
[TBL] [Abstract][Full Text] [Related]
29. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
Sone S; Mutsuura S; Ogawara M; Tsubura E
J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
[TBL] [Abstract][Full Text] [Related]
30. Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells.
Sakita M; Kageyama N; Majima S
Oncology; 1985; 42(4):259-64. PubMed ID: 4011111
[TBL] [Abstract][Full Text] [Related]
31. Synergistic induction of cytotoxicity in macrophages by murine interferon-gamma and biological response modifiers derived from microorganisms.
Nagao S; Sato K; Osada Y
Cancer Immunol Immunother; 1986; 23(1):41-5. PubMed ID: 3094943
[TBL] [Abstract][Full Text] [Related]
32. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
Sone S; Tsubura E
J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
[TBL] [Abstract][Full Text] [Related]
33. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
Howard AD; Erickson KL
Cell Immunol; 1995 Aug; 164(1):105-12. PubMed ID: 7634340
[TBL] [Abstract][Full Text] [Related]
34. Selective macrophage activation by muramyldipeptide bound to monoclonal antibodies specific for mouse tumor cells.
Roche AC; Bailly P; Midoux P; Monsigny M
Cancer Immunol Immunother; 1984; 18(3):155-9. PubMed ID: 6568872
[TBL] [Abstract][Full Text] [Related]
35. Macrophage activation for antitumour function by muramyl dipeptide-protein conjugates.
Tabata Y; Ikada Y
J Pharm Pharmacol; 1990 Jan; 42(1):13-9. PubMed ID: 1969943
[TBL] [Abstract][Full Text] [Related]
36. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
[TBL] [Abstract][Full Text] [Related]
37. Stimulatory effects of muramyl dipeptide and its butyl ester derivative on the proliferation and activation of macrophages in vitro.
Schindler TE; Coffey RG; Hadden JW
Int J Immunopharmacol; 1986; 8(5):487-98. PubMed ID: 3019904
[TBL] [Abstract][Full Text] [Related]
38. Scavenger receptor-mediated delivery of muramyl dipeptide activates antitumor efficacy of macrophages by enhanced secretion of tumor-suppressive cytokines.
Srividya S; Roy RP; Basu SK; Mukhopadhyay A
J Leukoc Biol; 2000 May; 67(5):683-90. PubMed ID: 10811009
[TBL] [Abstract][Full Text] [Related]
39. Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages.
Brunda MJ; Sulich V; Wright RB; Palleroni AV
Int J Cancer; 1991 Jul; 48(5):704-8. PubMed ID: 1906430
[TBL] [Abstract][Full Text] [Related]
40. Tumor cell binding and induction of endothelial cell tumoricidal activity in vitro by muramyl dipeptide is enhanced by liposomal encapsulation.
Phillips NC; Stewart-Phillips J; Wang P
J Immunother Emphasis Tumor Immunol; 1994 Apr; 15(3):185-93. PubMed ID: 8032541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]